CME Group Inc (CME)
CME Group Inc (CME) carries a ŷRobot AI score of 51 out of 100. The model's fair value estimate is $291.69, 8.3% below the last close of $317.97. The chart signal reads Sell.
| Metric | CME |
|---|---|
| AI score | 51 / 100 |
| Chart signal | Sell |
| Fair value estimate | $291.69 |
| Upside to fair value | -8.3% |
| Previous close | $317.97 |
| P/E | 25.05 |
| Price / sales | 15.74 |
| Market cap | $113.06B |
| EPS | 11.79 |
| Revenue growth | 8.7% |
| 1-year price change | 10.2% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Financial Services stocks: JPMorgan Chase & Co, Visa Inc. Class A, Mastercard Inc, Bank of America Corp, HSBC Holdings PLC ADR, Morgan Stanley.
Questions about CME
Is CME overvalued or undervalued right now?
As of Oct 22, 2026, ŷRobot's fair-value model estimates CME Group Inc (CME) at $291.69 against a last close of $317.97, implying 8.3% downside to the model's estimate.
Is CME's chart signal bullish or bearish?
The chart-signal model classifies CME as Neutral as of Nov 13, 2026, with a signal score of -0.11 on a -1 to 1 scale.
What is CME's ŷRobot AI score?
CME scores 51 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is CME stock expensive on P/E and P/S?
CME trades at 25.1 times earnings and 15.7 times sales as of Nov 13, 2026.
What does CME's seasonal forecast show?
ŷRobot's seasonal forecast curve for CME reads +3.9% at 30 days, +7.6% at 90 days, and +10.2% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is CME growing?
CME Group Inc's revenue growth is +8.7% and free-cash-flow growth is +1.3% on the latest reported figures.
CME chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.